Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
VTGN similar filings
- 18 May 20 The Proposed Phase 2A Open-label Study will be Conducted in New York City
- 28 Apr 20 VistaGen Expands PH94B Clinical Development to Include Adjustment Disorder Related to COVID-19
- 27 Apr 20 Entry into a Material Definitive Agreement
- 3 Apr 20 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- 26 Mar 20 VistaGen Therapeutics Announces Common Stock Purchase Agreement for up to $10.25 Million
- 21 Feb 20 VistaGen Announces Positive Results of Newly Published Exploratory Phase 2a Study of PH10 for Rapid-Onset Treatment of Major Depressive Disorder
- 13 Feb 20 VistaGen Therapeutics Reports Fiscal 2020 Third Quarter Financial Results and Provides CNS Pipeline Overview
Filing view
External links
Exhibit 99.1